Drawing for FOXO

USPTO serial 88732535

FOXO

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
EISNACH, MICHAEL PATRICK
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with FOXO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

HEATHER KLIEBENSTEIN

HEATHER KLIEBENSTEIN MERCHANT & GOULD P.C.P.O. BOX 2910MINNEAPOLIS, MN 55402UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Epigenetic test kits comprising reagents for testing and analyzing saliva for non-medical purposes; Reagent kits and beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic purposesACTIVE—
005Medical diagnostic reagents; Clinical medical diagnostic reagentsACTIVE—
009Computer systems, namely, computer hardware, downloadable computer software, and downloadable electronic data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes, and excluding software that facilitates communication, collaboration, networking and the sharing of medical information and imaging between medical professionals with other medical professionals and medical service providers; Downloadable computer software for data collection, management, and analysis of molecular health, genetic and epigenetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes, excluding software that facilitates communication, collaboration, networking and the sharing of medical information and imaging between medical professionals with other medical professionals and medical service providersACTIVE—
036Annuity underwriting; Insurance information and consultancy; Insurance services, namely, insurance eligibility review and verification and consultation in the life insurance industry; Insurance services, namely, underwriting, issuing and administration of life and long-term care insurance and annuitiesACTIVE—
041Providing an online resource center, namely, online non-downloadable articles and papers in the fields of longevity, aging, genetic and epigenetic testing and genotyping and genomic technologies; Providing a website featuring online non-downloadable publications in the nature of articles, journals, brochures, leaflets, guides and manuals in the fields of longevity, aging, genetic and epigenetic testing and genotyping and genomic technologies; Providing an online publication in the nature of an non-downloadable interactive encyclopedia in the fields of longevity, aging, genetic and epigenetic testing and genotyping and genomic technologies; Educational services, namely, providing seminars, workshops, customer trainings and tutorials in the fields of, and for use in the fields of, health and aging tips and strategies, disease prevention, nucleic acid sequencing, genetics, epigenetics, genotyping, genomics, metagenomics, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, population research, and actuarial services; Providing non-downloadable electronic newsletters and online non-downloadable electronic newsletters delivered via email for use in the fields of health and aging tips and strategies, disease prevention, nucleic acid sequencing, genetics, epigenetics, genotyping, genomics, metagenomics, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, population research, and actuarial services; Educational services, namely, providing training of clinicians, scientists, researchers and medical professionals in the use of scientific equipment, instruments and techniques, namely, genomic sequencers, molecular diagnostic technologies, microarray technologies, DNA extraction, bioinformatics, and automated laboratory apparatus; Providing facilities for training in operation and use of scientific equipment, instruments and techniques, namely, genomic sequencers, molecular diagnostic technologies, microarray technologies, DNA extraction, bioinformatics, and automated laboratory apparatusACTIVE—
042Providing scientific analysis in the field of personal epigenetics; Reporting of consumer authorized molecular health, aging and longevity results direct to the consumer for non-medical purposes, namely, epigenetic testing, analysis and evaluation of saliva; Testing, analysis and evaluation of DNA for epigenetic patterns associated with alcohol and tobacco use and other traits about an individual for non-medical purposes; Providing an interactive website featuring technology that allows users to enter, access, track, monitor and generate information and reports in the fields of personal epigenetics, health and wellnessACTIVE—
044Medical testing for screening, diagnostic or prognostic purposes; DNA sequencing, screening, and analysis services for medical diagnostic purposes; Nucleic acid sequencing, screening, and analysis services for medical diagnostic purposes; Genomic sequencing, screening, and analysis services for medical diagnostic purposes; Genetic and epigenetic analysis and reporting services for medical diagnostic purposes; Medical diagnostic testing, monitoring and reporting services in the field of infectious disease identification and surveillanceACTIVE—
045Online social networking services in the field of longevity, aging, genetics and epigeneticsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 22, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 22, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 19, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 9, 2023TMBNTTAB RELEASE CASE TO TRADEMARKS—
Aug 9, 2023OP.TOPPOSITION TERMINATED NO. 999999—
Aug 9, 2023OP.DOPPOSITION DISMISSED NO. 999999—
Mar 2, 2023OP.IOPPOSITION INSTITUTED NO. 999999—
Mar 2, 2023OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Jan 31, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 31, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 11, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 22, 2022CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Dec 19, 2022APETASSIGNED TO PETITION STAFF—
Dec 1, 2022ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Nov 25, 2022EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
May 24, 2022ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
May 24, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 24, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 4, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 20, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 31, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 30, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 30, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 17, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 17, 2021EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Nov 17, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 17, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 30, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 30, 2021RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Aug 12, 2021DOCKASSIGNED TO EXAMINER—
Jul 30, 2021RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jul 9, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 9, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 9, 2021EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jul 9, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 9, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 9, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 19, 2021ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 14, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 14, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Oct 14, 2020CNSLSUSPENSION LETTER WRITTEN—
Sep 22, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 21, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 21, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 21, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 17, 2020DOCKASSIGNED TO EXAMINER—
Feb 12, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 23, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 21, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance